End-stage heart failure is the common result of an acute or chronic injury to the heart. Currently there is no effective treatment for these patients and they will subsequently require a left ventricle assist device or a heart transplant. Now researchers are spotlighting a large study showing that cell therapy might one day be the answer for these patients.
